Chemistry, part 1

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > sulfonamide > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > sulfur oxoacid derivative > sulfonic acid derivative > sulfonamide > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxoacid derivative > sulfur oxoacid derivative > sulfonic acid derivative > sulfonamide > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > sulfonamide > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

... > organooxygen compound > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxadiazole > 1,3,4-oxadiazoles > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

organic heterocyclic compound > organonitrogen heterocyclic compound > oxadiazole > 1,3,4-oxadiazoles > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide

organic heterocyclic compound > organic heteromonocyclic compound > oxadiazole > 1,3,4-oxadiazoles > 3-/{5-[(1r)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl/}-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide